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Fibrillar fibronectin plays a key role as nucleator of
collagen I polymerization during macromolecular
crowding-enhanced matrix assembly†
Jenna Graham, a Michael Raghunath b and Viola Vogel *a
Macromolecular crowding is used by tissue engineers to accelerate extracellular matrix assembly in vitro,
however, most mechanistic studies focus on the impact of crowding on collagen fiber assembly and
largely ignore the highly abundant provisional matrix protein fibronectin. We show that the accelerated
collagen I assembly as induced by the neutral crowding molecule Ficoll is regulated by cell access to
fibronectin. Ficoll treatment leads to significant increases in the amount of surface adherent fibronectin,
which can readily be harvested by cells to speed up fibrillogenesis. FRET studies reveal that Ficoll crowd-
ing also upregulates the total amount of fibronectin fibers in a low-tension state through upregulating
fibronectin assembly. Since un-stretched fibronectin fibers have more collagen binding sites to nucleate
the onset of collagen fibrillogenesis, our data suggest that the Ficoll-induced upregulation of low-tension
fibronectin fibers contributes to enhanced collagen assembly in crowded conditions. In contrast, chemi-
cal cross-linking of fibronectin to the glass substrate prior to cell seeding prevents early force mediated
fibronectin harvesting from the substrate and suppresses upregulation of collagen I assembly in the pres-
ence of Ficoll, even though the crowded environment is known to drive enzymatic cleavage of procolla-
gen and collagen fiber formation. To show that our findings can be exploited for tissue engineering appli-
cations, we demonstrate that the addition of supplemental fibronectin in the form of an adsorbed coating
markedly improves the speed of tissue formation under crowding conditions.
Introduction
Since the in vitro growth of engineered tissue substitutes is
time consuming and thus expensive, a primary challenge
taken on by tissue engineers is to define methods to speed up
the assembly of native extracellular matrix (ECM) by cells
in vitro. Important factors contributing to the success of a
tissue engineered product besides the speed of assembly are
its physical stability, how close the physical and biochemical
properties are to native ECM, cell viability, cell proliferation,
and cell phenotype. In recent years, macromolecular crowding
has been applied to tissue engineering to improve the success
of tissue assembly in vitro.1–3 Molecular crowding results in
much faster ECM assembly, as well as more native matrix
architecture, enhanced matrix remodeling, and reduced cellu-
lar phenotypic drift (see ESI Table 1† for a summary of litera-
ture concerning the use of crowding in tissue engineering).
The term macromolecular crowding describes the phenom-
enon where soluble macromolecules in a fluid take up space
(excluded volume) and thereby affect the behavior of neighbor-
ing molecules whose available volume and thus conformation-
al freedom are decreased,4,5 resulting in more compact protein
conformations. Crowding also slows diffusion, enhances the
interaction of molecules, their aggregation, and enhances
adsorption of proteins onto surfaces.4,6–10 Since the in vivo
extracellular environment contains 9%–45% volume fraction
of macromolecules (FVO),11 various artificial crowding agents
have been added to cell culture to mimic in vivo crowding. One
of the most commonly used crowding mimics is a mixture of
two types of Ficoll (ESI Table 1†), a neutral, synthetic
polysucrose12–17 that has been FDA approved for clinical and
in vitro applications.18,19 The mixture of 37.5 mg mL−1 70 kDa
and 25 mg mL−1 400 kDa Ficoll creates a crowded solution
with an FVO of approx. 18% v/v which replicates the crowding
level in blood plasma2,12,20 and has proven effective in enhan-
cing matrix assembly.11–17,21–23 Even though negatively
charged crowding molecules like carrageenan have a stronger
enhancing effect on matrix assembly, they have an unequal
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impact on different matrix components (e.g. they have a much
stronger enhancing effect on collagen I than fibronectin) and
therefore result in a change in the composition of the
ECM.22,24–26
Crowding has been shown to enhance the assembly of a
wide range of ECM molecules, including fibronectin, collagen
types I–VII, laminin, fibrillin, vitronectin, heparin sulfate pro-
teoglycan, hyaluronic acid, decorin, lysyl oxidase, tenascin C,
and thrombospondin (see Chen et al.2 for a more complete
list). However, it is best described how crowding enhances
assembly of collagen type I. Crowding enhances enzymatic
cleavage of cell-secreted procollagen, both in a cell-free col-
lagen gel assay and in cell culture,1,2,20,21,27–29 and crowding
promotes collagen self-association in cell-free systems.2,30,31
Additionally, crowding increases transglutaminase 2 and lysyl
oxidase cross-linking of collagen, as shown in cell culture.1,2
Finally, a fragment produced from the activation of procolla-
gen C proteinase enhancer 1 has been found to act as a matrix
metallopeptidase 2 inhibitor,21,32 thereby reducing the enzy-
matic digestion of the assembled collagen matrix.
In contrast to collagen, how crowding increases the assem-
bly of fibronectin is not known. Fibronectin is the very first
matrix molecule actively assembled into provisional ECM
fibers by cells.33–37 Though crowding drives supramolecular
assembly, and should thus increase fibronectin–fibronectin
binding, fibronectin fibrillogenesis is tightly regulated and
requires fibronectin stretching to expose cryptic Fn–Fn
binding sites.38–42 Additionally, there is no enzymatic cleavage
required to initiate fibronectin assembly, so crowding cannot
be acting on fibronectin through this known mechanism.
Given the important role of cell–fibronectin interactions in
fiber assembly, crowding likely has another mechanism to
increase fibronectin assembly that has not yet been identified.
It is also unknown what role fibronectin might play in the
assembly of other ECM molecules in the presence of crowding.
In early phases of ECM assembly, the initiation of collagen I
polymerization into fibers needs to be nucleated. The nuclea-
tion of collagen I polymerization in vivo is initiated by fibro-
nectin fibers which act as templates for collagen peptides to
bind, similarly to the role of seeds that initiate biomineraliza-
tion processes. In fact, even though collagen gels can be
formed from a solution of collagen monomers in vitro, i.e. by
lowering the pH and increasing the temperature, these
initiation conditions are not typically exploited in cell culture
and collagen matrix cannot be formed in vivo without the pres-
ence of fibronectin.43–46 Importantly, though, early fibronec-
tin-collagen binding is mechano-regulated as collagen pep-
tides can tightly bind only to structurally relaxed but not to
highly stretched fibronectin fibers.35,47 Additionally, fibronec-
tin binds to and enhances the procollagen cleavage activity of
bone morphogenic protein 1 48,49 and plays a role in regulating
the activity of the collagen cross-linker lysyl oxidase.50
Given the significant interactions between fibronectin and
collagen during matrix assembly, we asked here for the first
time how fibronectin might regulate crowding-enhanced col-
lagen I matrix assembly. To gain insights to how crowding
increases fibronectin assembly over time, we supplemented
fluorescently labeled fibronectin isolated from human
plasma51 to the cell media. We explored how crowding affects
crucial mechanical cell functions and the cell ability to scrape
off fibronectin from the substrate. Since fibronectin tension
regulates the nucleation of collagen I polymerization, we next
used our well-validated fibronectin-FRET probe40,47,51–62 to
assess how crowding affects the tensional state of fibronectin
fibers within the matrix. We then manipulated the matrix
assembly process in the presence of crowding by adjusting
the adhesion of fibronectin to the glass substrate surface to
assess the role of fibronectin fibers versus surface adsorbed
fibronectin coating in matrix assembly. Finally, we explored
how our findings might be exploited for tissue engineering
applications.
Results
Ficoll increases assembly of fibronectin and collagen I fibers
in the first 16 hours and they are colocalized
To take a close look at the impact of crowding on the early
phases of ECM assembly, and particularly the interaction
between fibronectin and collagen I, we cultured primary
human dermal fibroblasts in the absence or presence of the
standard Ficoll mixture (37.5 mg mL−1 70 kDa + 25 mg mL−1
400 kDa, GE Healthcare). Before adding fibroblasts, we
adsorbed human plasma fibronectin to the glass substrate
(50 μg mL−1, 1 hour). It was previously shown that fibroblasts
harvest fibronectin from the substrate surface and incorporate
it into fibers, along with soluble plasma fibronectin from
serum and their own cell produced cellular fibronectin,63,64 as
also observed here (ESI Movie 1†). Note in ESI Movie 1† that
the cells stop scraping off fibronectin from the surface while
rounding up and going through a cell division. We then spar-
sely seeded fibroblasts at 5000 cells per cm2 and allowed them
to adhere for 1 hour. We chose to start with a very low cell
seeding density to allow for better visualization of the inter-
action of fibroblasts with the fibronectin coating and early
matrix assembly. Next, the media were exchanged and fibro-
blasts were exposed to Ficoll (+Ficoll) or cultured in standard
medium without crowders (−Ficoll). In both cases, 50 μg mL−1
of human plasma fibronectin and 100 μM L-ascorbic acid
2-phosphate were supplemented to the cell culture media to
promote matrix assembly. A small portion (10%) of the fibro-
nectin supplemented to the media and in the coating was
fluorescently labeled (Alexa-647) to enable its visualization.
Significant matrix assembly took place during the first
16 hours, both in the absence and presence of Ficoll (Fig. 1A
and B). Early fibronectin and collagen I fibers were colocalized
in both conditions, as shown by the intensity linescans in
Fig. 1A and B and by ESI Movie 2.† Ficoll did not have an
impact on cell density after 16 hours (Fig. 1C). Quantification
of fibronectin and collagen I by summing the respective fluo-
rescent pixel intensities showed that there was already more of
both matrix proteins with Ficoll treatment after only 16 hours
Paper Biomaterials Science






















































































Fig. 1 Ficoll supplementation accelerates ECM assembly within the first 16 hours and fibronectin and collagen I are colocalized. (A) ECM assembled
without Ficoll. The first row shows a widefield fluorescence image of fibroblasts and matrix followed by images of Alexa-647-labeled fibronectin and
antibody-stained collagen I alone. The second row shows a magnified area of the image above, followed by an image of matrix only and
intensity linescans of fibronectin and collagen I along the white line indicated in the matrix only image to the left. (B) ECM assembled with Ficoll
mixture (37.5 mg mL−1 70 kDa Ficoll + 25 mg mL−1 400 kDa). (C) Cell density. (D) Summed intensity of Alexa-647-labeled fibronectin. (E) Summed
intensity of antibody-stained collagen I. (F) Area of substrate covered by fibronectin fibers as quantified using a threshold set to distinguish fibers
from background and coating. 30–100 images were analyzed for each condition (10 for total fibronectin in -Ficoll condition). D–F show values nor-
malized to the mean without Ficoll. Glass substrates preadsorbed with 50 μg mL−1 plasma fibronectin (10% Alexa-647-labeled). Cells cultured in
MEM Alpha supplemented with 10% fetal bovine serum, 1% penicillin–streptomycin, 100μM L-ascorbic acid 2-phosphate, and 50 μg mL−1 plasma
fibronectin (10% Alexa-647-labeled). **indicates p < 0.01, ****indicates p < 0.0001. Respective greyscale images of each channel can be found in ESI
Fig. 1.† ESI Movie 2† shows alternating images of fibronectin and collagen I to appreciate their spatial correlation. Fibronectin matrix quantification
by antibody staining can be found in ESI Fig. 4.†
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(Fig. 1D and E). Notably, the effect of Ficoll on fibronectin
deposition was stronger than on collagen I (1.9× vs. 1.7×,
respectively). Additionally, the fibronectin matrix assembled
with Ficoll covered approximately twice the area of that
assembled without Ficoll (2.1×, Fig. 1F).
Collagen I fibers mostly continue to colocalize with
fibronectin fibers after 2 days of Ficoll exposure
Assembly of fibronectin and collagen I fibers remained
enhanced under Ficoll treatment as fibroblasts were cultured
for 2 days with respect to the control (Fig. 2). Importantly, as
matrix assembly progressed, collagen I was still colocalized
with fibronectin during the first few days, as shown by the
intensity line scans in Fig. 2A and B and by ESI Movie 3.† Cell
density had more than doubled since 16 hours and was still
not impacted by Ficoll (Fig. 2C). Quantification of matrix pro-
teins showed that Ficoll increased fibronectin fiber assembly
more than collagen I also at this time point (2.6× vs. 1.8×,
Fig. 2D and E). Ficoll induced fibronectin matrix covered
about twice the area compared to the control without Ficoll
(Fig. 2F).
A dense ECM was assembled in 6 days both with and without
Ficoll
To ask how effective Ficoll treatment is during the early versus
late phases of cell culture, we continued the experiment
further to six days, at which point the fibroblasts had reached
confluence and developed a very dense matrix (Fig. 3A and B).
The collagen I fibers showing the brightest immunolabel
signal were still generally in close proximity to the fibronectin
fibers, both with and without Ficoll, as can be appreciated in
the z-stack shown in ESI Movie 4.† However, the depth and
density of the ECM made it difficult to determine if collagen I
was still strictly co-localized with fibronectin. Previous
studies suggest that, by this time point, collagen I fibers have
become increasingly interconnected and are no longer
restricted to the fibronectin template.47 After 6 days, fibro-
blasts had reached a confluent state and the cell density was
the same with and without Ficoll (Fig. 3C). Quantification of
fibronectin and collagen I showed that matrix assembly in
non-Ficoll treated samples caught up significantly and the
differences with Ficoll were quite small compared to earlier
time points (Fig. 3D and E). Taken together, this time series
from 16 hours to 6 days (Fig. 1–3) highlights the fact that Ficoll
substantially accelerated the early matrix assembly process,
while its effect evened out by 6 days when non-Ficoll-treated
cultures caught up in terms of matrix assembly. ESI Fig. 4†
shows that the results were the same when fibronectin was
quantified not by Alexa-647-labeling of plasma fibronectin, but
by antibody staining, as is standard in the field.
Increased fibronectin fiber assembly is not attributable to
changes in selected fibroblast functions
Given that fibronectin fibrillogenesis depends on traction
forces, we next asked whether Ficoll upregulates cell contracti-
lity or any other cell functions related to matrix assembly. We
cultured cells as before, except without fibronectin supplemen-
tation since this is not standard in the field, and analyzed
them after 24 hours exposure to Ficoll. We measured cell
spreading area and found no change with Ficoll (Fig. 4A). We
then measured phosphorylation of focal adhesion kinase
(pFAK), which is downstream of integrin ligation,65 and found
that this was also not changed by Ficoll treatment (Fig. 4B).
We then assessed cell contractility by measuring the phos-
phorylation of myosin light chain 2 (p-MLC2), which was
unchanged (Fig. 4C), as well as the amount of filamentous
actin (F-actin) per cell, which increases with cell traction
forces, and also remained unchanged (Fig. 4D). Fibroblasts
could also have increased migration and/or membrane activity
that results in increased harvesting of the fibronectin coating.
We estimated the area of coating harvested per cell by dividing
the total area per image where the fibronectin coating had
been removed by the number of cells in that image. This was
also unchanged with Ficoll (Fig. 4E). We then measured
several nuclear markers that are known to be sensitive to
mechanical interactions of cells with their environment. We
found no significant changes in the ratio of lamin A to lamin
B, the nuclear-to-cytoplasmic ratio of transcription factors yes-
associated protein (YAP) and myocardin-related transcription
factor-A (MRTF-A), or the histone markers acetylation of
histone 3 at lysine 9 (H3K9Ac) and trimethylation of histone 3
at lysine 27 (H3K27me3) (Fig. 4F–J). Taken together, these
results show that there were no apparent changes in cell behav-
ior that could explain the increased fibronectin fiber assembly
with Ficoll.
Ficoll increases the amount of fibronectin at the glass surface
where it is easily accessible for cell mediated fiber assembly
Next we asked whether Ficoll regulates cell access to fibronec-
tin since crowding has been shown to increase the adsorption
of molecules from the bulk fluid onto surfaces.66,67 In order to
assemble fibers, cell surface integrins need to bind to fibro-
nectin, much of which is soluble in the medium, either
coming from serum supplement or secreted by the cells them-
selves. Ficoll could cause increased adsorption of soluble fibro-
nectin from the medium to the glass surface during extended
cell culture. To investigate this, we cultured cells for 2 days
with and without Ficoll and, after sample fixation, analyzed
antibody-stained fibronectin on the glass surface in areas
where the coating was left undisturbed (no apparent harvest-
ing, no cells, no fibers). We switched to antibody staining for
fibronectin quantification to ensure that we labeled both cellu-
lar and plasma fibronectin, and because this is standard in the
field. We also did not add supplemental plasma fibronectin to
the medium to correlate with previous studies where this had
not been done (data with supplemental fibronectin shown in
ESI Fig. 5†). As evident from the images in Fig. 5A, the amount
of fibronectin at the surface was increased significantly in the
presence of Ficoll. Quantification of the intensity of fibronec-
tin stain showed 2.3× more fibronectin per area on the glass
surface in the Ficoll treated condition (Fig. 5B). This means
that, though the glass substrates were initially preadsorbed
Paper Biomaterials Science






















































































Fig. 2 Ficoll treatment continues to accelerate assembly of fibronectin and collagen I fibers throughout 2 days and they are still mostly colocalized.
(A) ECM assembled without Ficoll. The first row shows a widefield fluorescence image of fibroblasts and matrix followed by images of Alexa-647-
labeled fibronectin and antibody-stained collagen I alone. The second row shows a magnified area of the image above, followed by an image
of matrix only and intensity linescans of fibronectin and collagen I along the white line indicated in the matrix only image to the left. (B) ECM
assembled with Ficoll. (C) Cell density. (D) Summed intensity of Alexa-647-labeled fibronectin. (E) Summed intensity of antibody-stained collagen I.
(F) Area of substrate covered by fibronectin fibers as quantified using a threshold set to distinguish fibers from background and coating. 50–120
images were analyzed for each condition. D–F show values normalized to the mean without Ficoll. Glass substrates preadsorbed with 50 μg mL−1
plasma fibronectin (10% Alexa-647-labeled). Cells cultured in MEM Alpha supplemented with 10% fetal bovine serum, 1% penicillin–streptomycin,
100 μM L-ascorbic acid 2-phosphate, and 50 μg mL−1 plasma fibronectin (10% Alexa-647-labeled). ***indicates p < 0.001, ****indicates p < 0.0001.
Respective greyscale images of each channel can be found in ESI Fig. 2.† ESI Movie 3† shows alternating images of fibronectin and collagen I to
appreciate their spatial correlation. Fibronectin matrix quantification by antibody staining can be found in ESI Fig. 4.†
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Fig. 3 ECM assembly after 6 days with and without Ficoll. (A) ECM assembled without Ficoll. The first row shows a widefield fluorescence image of
fibroblasts and matrix followed by images of Alexa-647-labeled fibronectin and antibody-stained collagen I alone. The second row shows a
magnified area of the image above: first cells and matrix, followed by images of fibronectin and collagen I alone. (B) ECM assembled with Ficoll. (C)
Cell density. (D) Summed intensity of Alexa-647-labeled fibronectin. (E) Summed intensity of antibody-stained collagen I. 70–150 images were ana-
lyzed for each condition (30 images analyzed for cell density). D and E show values normalized to the mean without Ficoll. Glass substrates pread-
sorbed with 50 μg mL−1 plasma fibronectin (10% Alexa-647-labeled). Cells cultured in MEM Alpha supplemented with 10% fetal bovine serum, 1%
penicillin–streptomycin, 100 μM L-ascorbic acid 2-phosphate, and 50 μg mL−1 plasma fibronectin (10% Alexa-647-labeled). ****indicates p < 0.0001.
Respective greyscale images of each channel can be found in ESI Fig. 3.† ESI Movie 4† shows a z-stack of 6 day matricies produced with and without
Ficoll to appreciate the spatial correlation of fibronectin and collagen I. Fibronectin matrix quantification by antibody staining can be found in ESI
Fig. 4.†
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with fibronectin, Ficoll treatment caused additional soluble
fibronectin from the media to deposit to the glass surface over
2 days of culture.
With the Ficoll-induced increase in fibronectin matrix there is
more un-stretched fibronectin to act as a template for collagen
I assembly
Since collagen I assembly is nucleated by binding to low
tension rather than highly stretched fibronectin fibers, as fiber
stretching destroys the multivalent binding motif by which col-
lagen peptides bind to several fibronectin type I and II
modules in a row,47 similarly to how fiber stretching destroys
the binding sites of bacterial adhesins,68,69 we next asked if
Ficoll results in a greater total amount of un-stretched fibro-
nectin fibers that could initiate polymerization of collagen I
during the early stages of matrix assembly with our well vali-
dated FRET-fibronectin probe.40,47,51–62 Ten percent of the sup-
plemented plasma fibronectin was FRET-labeled and was
incorporated into the matrix assembled by cells, as observed
before.40,54 The glass was preadsorbed with unlabeled fibro-
nectin to distinguish freshly assembled ECM fibers from that
adsorbed to the glass substrate. Cell seeding density was
doubled (10 000 cells per cm2) to ensure that we had enough
fibronectin-FRET signal in an early stage of matrix assembly.
Fig. 6A shows representative images of FRET ratios after 2
days, with and without Ficoll. A histogram of all FRET ratios
compiled from 21 images for each condition appears in
Fig. 6B. The overall peak tensional state of the matrix did not
change, which is consistent with our finding that cell contrac-
tility did not increase (Fig. 4C). However, the total number of
high-FRET pixels was higher upon Ficoll treatment (Fig. 6B).
To further assess fibronectin’s conformational states, we used
different concentrations of the chemical denaturant guanidine
hydrochloride (GdnHCl) to gradually denature fibronectin in
solution, measured the resulting fibronectin-FRET ratios, and
created a calibration curve for our FRET-labeled fibronectin
probe, as done before40,54 (ESI Fig. 6†). Fibronectin in 1 M
GdnHCl is extended compared to the globular state in PBS,
but has not yet lost its secondary structure, whereas fibronec-
tin in 4 M GdnHCl has lost its secondary structure and is com-
pletely denatured.53 Fibronectin fibrillogenesis is initiated by
stretch-induced opening of cryptic fibronectin–fibronectin
binding sites35 and, as cells start bundling fibronectin profila-
ments into thicker fibers,70 they can get further stretched up
Fig. 4 Ficoll has no major effect on vital cell mechanical functions. Protein levels were assessed at the single cell level by immunofluorescence
microscopy after 24 hours of Ficoll treatment compared to control. (A) Cell area. (B) Summed intensity of phosphorylated focal adhesion kinase per
cell. (C) Summed intensity of phosphorylated myosin light chain 2 per cell. (D) Summed intensity of filamentous actin per cell. (E) Percent of image
field of view with fibronectin coating removed, divided by the number of cells in the image. Approximately 20 images analyzed per condition. (F)
Ratio of average intensity of lamin A to lamin B. (G) Ratio of average intensity of yes-associated protein in the nucleus to the cytoplasm. (H) Ratio of
average intensity of myocardin-related transcription factor-A in the nucleus to the cytoplasm. (I) Summed intensity of acetylation of histone 3 at
lysine 9 in the nucleus. (J) Summed intensity of trimethylation of histone 3 at lysine 27 in the nucleus. For A–D and F–J, each data point represents
one cell. At least 100 individual cells were analyzed per condition. All values except ratios were normalized to the average without Ficoll. Glass sub-
strates preadsorbed with 50 μg mL−1 unlabeled plasma fibronectin. Cells cultured in MEM Alpha supplemented with 10% fetal bovine serum, 1%
penicillin–streptomycin, and 100 μM L-ascorbic acid 2-phosphate, but no additional plasma fibronectin (aside from that in serum).
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to 3–4 times their equilibrium length in cell culture.56 To
quantify the amount of low tension fibronectin, we then quan-
tified the total number of pixels in each image with a FRET
ratio above that of fibronectin in 1 M GdnHCl (i.e. FRET ratio =
0.34). There was a 30% increase in the amount of low-tension
fibronectin with Ficoll at 2 days compared to −Ficoll control
(Fig. 6C). Taken together, the overall tensional state of the
fibronectin fibers was not changed with Ficoll, but the total
number of FRET pixels representing un-stretched fibronectin,
and thus potential nucleation sites for collagen I, was signifi-
cantly higher upon Ficoll treatment.
Cross-linking adsorbed fibronectin to the substrate inhibits
the Ficoll-accelerated matrix assembly
To ask how important surface adsorbed fibronectin might be
in the accelerated matrix assembly process as induced by
Ficoll, we covalently cross-linked fibronectin to the glass sub-
strate before cell seeding to prevent fibroblasts from scraping
off the coating and found that this significantly delayed early
assembly of fibronectin fibers. Fig. 7A shows antibody-stained
fibronectin and collagen I assembled on a cross-linked fibro-
nectin coating after 2 days. The dark, cell-shaped areas in the
fibronectin channel in Fig. 7A are shadows where the fibronec-
tin antibody was not able to access the coating, which we con-
firmed by removing the cells with trypsin (ESI Fig. 7†). Even
though it is known that Ficoll drives the cleavage and assembly
of collagen I, we found that Ficoll did not increase collagen I
fiber assembly when the fibroblasts could not pull the fibro-
nectin coating off the substrate to accelerate early fibronectin
fibrillogenesis (Fig. 7B). In contrast, collagen I fiber assembly
was more than doubled by Ficoll on adsorbed fibronectin that
the fibroblasts could harvest during the early phase fibrillogen-
esis (Fig. 7C and D). This is an important novel finding that,
even though Ficoll was there to promote the enzymatic clea-
vage and supramolecular assembly of collagen, the fibronectin
fiber template was still essential for collagen I fiber assembly.
Preadsorbing fibronectin to the glass substrate further
accelerates matrix assembly under crowding conditions
To ask how bioengineers can take advantage of our findings,
we assessed the impact of preadsorbing fibronectin to the
glass substrate on matrix assembly in crowded conditions.
We cultured fibroblasts with Ficoll for 2 days on uncoated
glass (standard protocol in the community) or glass coated
with 50 μg mL−1 adsorbed human plasma fibronectin. We
found that the cell density was significantly higher when the
glass was preadsorbed with fibronectin (Fig. 8A), likely due to
both increased cell adhesion and proliferation, and that there
Fig. 5 Ficoll increases fibronectin adsorption to the glass surface during cell culture. (A) Widefield immunofluorescence images of antibody-stained fibro-
nectin after 2 days culture with and without Ficoll, with insets below showing undisturbed areas of fibronectin coating (no fibroblasts or ECM fibers) that
were analyzed. (B) Summed fibronectin intensity divided by area. Glass substrates preadsorbed with 50 μg mL−1 unlabeled plasma fibronectin. Cells cul-
tured in MEM Alpha supplemented with 10% fetal bovine serum, 1% penicillin–streptomycin, and 100 μM L-ascorbic acid 2-phosphate, but no additional
plasma fibronectin (aside from that in serum). See ESI Fig. 5† for results with plasma fibronectin supplemented to the medium. ****indicates p < 0.0001.
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was much more fibronectin and collagen I fiber assembly
than without precoating (Fig. 8B and C). We then added
50 μg mL−1 supplemental soluble plasma fibronectin to the
medium, in addition to the preadsorbed fibronectin coating,
to see if it further improved matrix assembly beyond the
coating alone. Note that 10% serum contains only 2–3 μg
mL−1 of fibronectin.71 Fig. 8D–F shows that addition of sup-
plemental soluble fibronectin minorly increased cell density
but did not impact fibronectin or collagen I assembly. These
results show that including fibronectin as a coating before
cell seeding markedly improved the matrix assembly with
macromolecular crowding in 2 days, but there was no further
benefit of also supplementing soluble fibronectin to the
medium.
Discussion and conclusion
Since methods to accelerate matrix production are urgently
needed in the fields of tissue engineering and regenerative
medicine, our goal here was to shed light on the underpinning
mechanisms by which Ficoll exposure upregulates ECM
assembly, as previously reported.11–17,21–23,72,73 Rather than
just accelerating pro-collagen cleavage and supramolecular
assembly, previously thought to be the main drivers,2,3 we
show here that Ficoll also significantly enhances fibronectin
assembly (Fig. 1–3) and that the rate of fibronectin fibrillogen-
esis regulates the collagen I assembly process. Towards the
mechanistic side, we found that fibronectin and collagen I are
colocalized during early ECM assembly both with and without
Fig. 6 Ficoll increases the number of nucleation sites that can induce collagen I polymerization as assessed by fibronectin-FRET, even though the
distribution of fibronectin strains is not significantly altered. (A) Confocal images of the fibronectin-FRET ratios at the glass surface (where early
matrix fibers are assembled) after 2 days in culture without and with Ficoll. (B) Representative FRET ratio histograms compiled from 21 images for
each condition: 7 images each from 3 different samples. The dotted vertical lines represent the average FRET ratios in 4 M GdnHCl (left) and in 1 M
GdnHCl (right) – see ESI Fig. 6† for calibration curve. (C) Number of pixels with FRET ratio above that of fibronectin in 1 M GdnHCl. Each point rep-
resents a single measurement from one image. Glass substrates preadsorbed with 50 μg mL−1 unlabeled plasma fibronectin. Cells cultured in MEM
Alpha supplemented with 10% fetal bovine serum, 1% penicillin–streptomycin, 100 μM L-ascorbic acid 2-phosphate, and 50 μg mL−1 plasma fibro-
nectin (10% FRET-labeled). **indicates p < 0.01.
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Fig. 7 Ficoll does not increase collagen I fiber assembly when the preadsorbed fibronectin coating is cross-linked to the substrate prior to cell
seeding. (A) Widefield immunofluorescence images of matrix assembled on cross-linked fibronectin coating (50 μg mL−1, unlabeled) after 2 days of
culture. The first image is of fibroblasts and matrix, followed by magnified images of fibronectin and collagen I alone. Dark areas in the fibronectin
channel are cell shadows, not harvested coating – see ESI Fig. 7† for confirmation. (B) Summed intensity of collagen I, normalized to the mean
without Ficoll. (C and D) Same for adsorbed fibronectin coating (50 μg mL−1, unlabeled). Cells cultured in MEM Alpha supplemented with 10% fetal
bovine serum, 1% penicillin–streptomycin, and 100 μM L-ascorbic acid 2 phosphate, but no additional plasma fibronectin (aside from that in serum).
****indicates p < 0.0001. ESI Movie 1† shows how cells are able to harvest an adsorbed fibronectin coating, which is inhibited by cross-linking of
fibronectin to the glass.
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Fig. 8 Supplementation of fibronectin as an adsorbed coating improves matrix assembly in the presence of Ficoll after 2 days. (A–C) Tissue pro-
duction in the presence of Ficoll on uncoated glass compared to glass coated with 50 μg mL−1 adsorbed human plasma fibronectin (unlabeled).
(A) Cell density. (B) Summed intensity of antibody-stained fibronectin. (C) Summed intensity of antibody-stained collagen I. B and C are normalized
to the mean value on uncoated glass. (D–F) Additional impact of adding 50 μg mL−1 soluble human plasma fibronectin (unlabeled) when there is
already an adsorbed fibronectin coating. Cells cultured in MEM Alpha supplemented with 10% fetal bovine serum, 1% penicillin–streptomycin, and
100 μM L-ascorbic acid 2 phosphate. ****indicates p < 0.0001.
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crowders (Fig. 1–3, ESI Movies 2–4†), and that even though the
cell mechanical functions are not significantly impacted
(Fig. 4), Ficoll causes a significant increase in soluble fibro-
nectin adsorbing from the medium to the substrate
surface (Fig. 5 and ESI Fig. 5†). We observed a high density of
bright fibronectin spots at the glass surface, but only in the
presence of Ficoll (Fig. 1–2 and ESI Fig. 5†), suggesting that
crowding causes aggregation of fibronectin, which likely con-
tributes to further increasing the amount of fibronectin that
the cells can harvest. The 2-fold increase in fibronectin at the
glass surface seen with Ficoll correlates well with the 2-fold
increase in early fibronectin fiber assembly (Fig. 1–2). Even
though the cell spreading area and the area of coating har-
vested per cell are not significantly affected by Ficoll (Fig. 4),
there is a significantly higher amount of fibronectin on the
surface which the fibroblasts can scrape off. Fibronectin har-
vesting from the substrate is much more effective than
from the medium because surface adsorbed fibronectin is in a
more open conformation with greater accessibility of cell-
binding sites than fibronectin in solution.53,74 Additionally,
fibroblasts can more readily exert tensional forces on surface-
bound than on freely floating fibronectin, which is important
since cells have to stretch fibronectin to induce its
fibrillogenesis.35,39,70
By exploiting our well-established fibronectin-FRET
probe,40,47,51–62 we could show that Ficoll significantly
increases the total amount of low-tension fibronectin fibers
(Fig. 6). This observation is highly significant since we showed
previously that fibronectin stretching destroys the multivalent
binding motif for the collagen peptide,35,47 and consequently,
only the low-tension fibronectin fibers can nucleate the initial
collagen I polymerization process in cell culture. A very recent
study showed that fibronectin also binds both procollagen and
the C-proteinase BMP-1, thereby acting as a template to
increase their interaction.49 This suggests that the increase in
fibronectin matrix with crowding could directly contribute to
enhanced cleavage of procollagen, implicating yet another role
for fibronectin in matrix assembly with crowding.
Since the rate by which fibronectin can be scraped off plays
a key role in Ficoll-enhanced ECM assembly, we next asked
whether chemical cross-linking to the substrate might slow the
matrix assembly rate. Indeed we found that crosslinking of the
pre-adsorbed fibronectin layer to the substrate abolished the
previously described ability of Ficoll to upregulate matrix
assembly (Fig. 7). This is a remarkable finding since it was
shown previously that Ficoll upregulates procollagen cleavage
and supramolecular assembly,1,2,20,21,27–31 and still, if the cells
cannot efficiently harvest surface bound fibronectin to build
fibers, Ficoll does not upregulate ECM assembly. We thus illu-
minate for the first time the essential role of fibronectin in the
underpinning mechanism by which Ficoll upregulates ECM
assembly.
But what can tissue engineers learn from having deeper
insights into the driving mechanism? Our finding that cross-
linking of fibronectin to the glass surface also prevents col-
lagen assembly, even in the presence of a neutral crowder
(Fig. 7), demonstrates that paying attention solely to the
crowder is not enough to catalyze collagen assembly in vitro.
While it is common among tissue engineers to expose their
materials to the medium before cell seeding, we show here
that preadsorbing human plasma fibronectin greatly acceler-
ates ECM production compared to the uncoated sample
(Fig. 8) and that crosslinking of the preadsorbed fibronectin
layer to the substrates destroys the accelerating effect of Ficoll
supplementation (Fig. 7). We found that after 6 days there is
no longer a large difference in the matrix assembled with and
without Ficoll (Fig. 3 and ESI Fig. 4†). Results in the literature
are mixed about whether the increased matrix with crowding
persists over long culture times or if the matrix assembly
without crowding eventually catches up11,15,17,24,26 (summar-
ized in ESI Table 2†). However, there seems to be a consensus
that crowding increases the speed of early matrix assembly, as
we too have shown (Fig. 1 and 2). This increase in speed in the
early phases is highly valuable in tissue engineering, where
the weeks to months traditionally needed to produce a substi-
tute tissue in vitro result in high costs, a long wait-time for the
patient, and changes in cell phenotype, limiting clinical success.
As tissue engineers move away from the use of standard
fetal bovine serum towards animal-free media,73 it will become
even more important to consider whether to supplement the
media with fibronectin and at what concentrations. As we have
shown here, it is highly beneficial to supplement purified
human plasma fibronectin in the form of an adsorbed coating
(Fig. 8). This may be even more impactful in cases where the
cells do not efficiently produce fibronectin on their own. Our
mechanistic insights give tissue engineers important new para-
meters to consider which can be tuned to effectively increase
the ECM assembly process.
Materials and methods
Isolation of human plasma fibronectin
Fibronectin was isolated from human plasma as described pre-
viously,54 with minor modifications. First, plasma (Blood Bank
Zurich, Switzerland) was spun at 3220g for 40 minutes at 8 °C.
10 mM EDTA was added to the supernatant and then the
supernatant was passed through a PD-10 desalting column
(GE Healthcare #17-0851-01). Next the supernatant was passed
through a poly-prep chromatography column (Bio-Rad
#7311550) pre-packed the day before with gelatin-sepharose 4B
(VWR #17-0956-01) to bind fibronectin. The column was then
washed with column buffer (PBS + 10 mM EDTA), followed by
1 M NaCl in column buffer, and 0.2 M Arginine (Carl Roth
#1655) in column buffer until the 280 nm absorbance of the
flow-through was <0.1. Finally, the fibronectin was eluted with
1 M arginine in column buffer and stored at −80 °C until
usage. The quality of fibronectin purification was confirmed
by western blot and Coomassie staining. Before usage in cell
culture, fibronectin was slowly thawed at 4 °C overnight and
the solvent was changed to PBS through dialysis with a Slide-
A-Lyzer Dialysis Cassette (ThermoFischer Scientific #66003).
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Substrate cleaning and fibronectin preadsorption
Glass coverslips were cleaned by soaking in 2% HellmaneX
solution (Hellma #9-307-010-507) with sonication for
30 minutes, followed by another 30 minutes without soni-
cation, and subsequently washed with deionized water and
blown dry. Coverslips were then coated by adsorbing human
plasma fibronectin from solution (50 μg mL−1 in PBS, 1 hour,
room temperature) and subsequently washed with PBS.
Coverslips were sterilized before cell culture by 15 minutes of
UV exposure in a biosafety cabinet.
Cell culture
Normal human dermal fibroblasts (PromoCell, Vitaris AG,
Switzerland) were cultured in standard medium consisting of
MEM Alpha (Biowest #L0475), 10% fetal bovine serum
(Biowest #S181H), and 1% penicillin–streptomycin (Gibco
#15140122). Fibroblasts were regularly passaged with 0.25%
Trypsin-EDTA (Invitrogen #25200-056) before reaching conflu-
ence and used at passage #6-9. Medium with crowders was pre-
pared by dissolving 37.5 mg mL−1 of 70 kDa Ficoll (GE
Healthcare #GE17-0310) and 25 mg mL−1 of 400 kDa Ficoll
(GE Healthcare #GE17-0300) in standard medium in a 37 °C
water bath. Once dissolved, Ficoll containing medium was fil-
tered through a 0.22 μm syringe filter. Standard medium with
no crowder was also filtered for control samples. This crowd-
ing formulation remained consistent throughout the study.
Extracellular matrix assembly
For ECM assembly experiments, fibroblasts were cultured on
coverslips coated with adsorbed fibronectin placed inside stan-
dard 12-well polystyrene tissue culture plates. After coating,
coverslips were washed with PBS and fibroblasts were plated in
standard medium at 5000 cells per cm2 and allowed to adhere
for 1 hour in a humidified incubator with 5% CO2. Afterwards,
media were changed to ±Ficoll as appropriate and sup-
plemented with 100 μM L-ascorbic acid 2-phosphate (Sigma
#A8960) and 50 μg mL−1 human plasma fibronectin purified
in house (see Methods section “Isolation of human plasma
fibronectin”). Fibroblasts were cultured for 16 hours, 2 days, or
6 days. Media were changed after 3 days for the 6-day samples.
Ascorbic acid and fibronectin were freshly added upon media
change.
Immunofluorescence and microscopy
ECM assembly was visualized by immunofluorescence
microscopy. Unless labeled-fibronectin was used, fibronectin
was stained with BD primary antibody #610077 (1 : 200) and
donkey anti-mouse-488 secondary antibody (Invitrogen
#A-21202, 1 : 200). Collagen was visualized with Abcam
primary antibody #34710 (1 : 200) and donkey anti-rabbit-546
secondary antibody (Invitrogen #A10040, 1 : 200). Actin was
visualized with Phalloidin 647 or 488 (Invitrogen, 1 : 500) and
DNA with Hoechst 33342 (Thermo Scientific #62249, 1 : 200).
Samples were first blocked in 5% w/v BSA (AppliChem GmbH
#A1391) in water for 1 hour, then incubated with primary anti-
body in 5% BSA for 1 hour at room temperature, followed by
washing with 1% BSA and incubation with secondary antibody
in 5% BSA for 1 hour at room temperature. Samples were then
permeabilized with 0.3% Triton X-100 (AppliChem #A4975) for
15 minutes, washed, and stained with actin and DNA dyes.
Samples were finally mounted with fluorescent mounting
medium (Dako #S3023) and allowed to dry overnight at room
temperature before imaging.
Phosphorylated FAK was immunolabeled with Abcam
primary antibody #81298 (1 : 400) and phosphorylated myosin
light chain 2 was immunolabeled with Cell Signaling
Technologies primary antibody #3671 (1 : 50). Both were visual-
ized with donkey anti-rabbit-546 secondary antibody
(Invitrogen #A10040, 1 : 200). MRTF-A was immunolabeled
with Abcam primary antibody #49311 (1 : 100), H3K9Ac with
Abcam primary antibody #4441 (1 : 150), and H3K27me3 with
Cell Signaling Technologies primary antibody #9733 (1 : 1600).
Each of these were then visualized in individual samples with
goat anti-rabbit 488 secondary antibody #A-11034 (1 : 200).
Lamin A and lamin B were co-stained with primary antibodies
ab8980 (Abcam, 1 : 200) and ab16048 (Abcam, 1 : 500) and sec-
ondary antibodies donkey anti-mouse 488 (Invitrogen
#A-21202, 1 : 200) and donkey anti-rabbit 546 (Invitrogen
#A10040), respectively. Staining proceeded as above, except
permeabilization occurred just after fixing and before primary
and secondary antibody incubations.
Images for quantification of ECM assembly and cell/
nuclear markers were taken on a Leica DMI6000B epifluores-
cence microscope with 20× 0.7NA HC PlanApo objective. A
mosaic of 20 images (5 × 4 grid) was captured to avoid bias in
selecting areas to image. An ROI was selected to avoid corners
where fluorescent lamp intensity was weaker. Some images
were also taken with a Leica SP5 confocal microscope to better
visualize small details and appreciate the dimensionality of
the matrix.
Labeling of fibronectin
Unless specified otherwise, fibronectin matrix assembly was
visualized by substituting 10% of the coating and sup-
plemented soluble fibronectin with fluorescently-labeled fibro-
nectin (5 μg mL−1 labeled + 45 μg mL−1 unlabeled).
Fibronectin was randomly labeled with fluorescent probes on
surface accessible lysine residues by amide bond formation, as
described before70 with minor modifications. After purifi-
cation of fibronectin, the solvent was changed from 1 M argi-
nine to labelling buffer (0.1 M NaHCO3 in PBS, pH 8.5)
through dialysis with a Slide-A-Lyzer Dialysis Cassette
(ThermoFischer Scientific #66003). Fibronectin in the dialysis
cassette was then incubated with a molar excess of Alexa Fluor
647 succinimidyl ester (Invitrogen #A20006). The molar excess
depended on the freshness of the dye and varied from 5–50
(lower values for more fresh dye). Fibronectin was then dia-
lyzed again to change the solvent to PBS.
For FRET measurements, fibronectin was randomly labeled
with Alexa 488 donor fluorophores on its amines via succini-
midyl ester conjugation and specifically labeled with Alexa 546
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acceptor fluorophores on the cysteines in fibronectin type III
modules FNIII7 and FNIII15 via maleimide conjugation, based
on previous protocols52,54,56 and as described by Ortiz Franyuti
et al.62 To validate successful labeling, the sensitivity of the
FRET-probe to progressive denaturation in increasing concen-
trations of guanidine hydrochloride (GdnHCl, Sigma #G4505)
was verified with a procedure slightly modified from what was
described previously.54 A coverslip was coated with 2% BSA for
30 minutes, then washed with distilled water and blown dry.
FRET-labeled fibronectin was dissolved in solutions of
GdnHCl ranging from 4 M to 0 M (dH2O control). A 2.5 μL
drop of each solution was placed on the coverslip and was
imaged in 5 ROIs above the glass-droplet interface with the
same microscope settings as used for the matrices (see
Methods section “Imaging of FRET in cell-assembled
matrices”). Average FRET ratios were calculated for each con-
centration and plotted as a denaturation curve.
Quantification of ECM and cell density
ECM assembly was quantified by summing fibronectin and
collagen intensity per image after background subtraction with
a custom MATLAB script. Cell density was quantified by auto-
mated segmentation of nuclei with a custom MATLAB script
for 16 hours and 2 day samples. 6 day samples were counted
manually because the density was too high for automatic
segmentation.
Quantification of fibronectin adsorbed to the glass surface
Fibroblasts were cultured on fibronectin coated glass as
described above, except without soluble fibronectin added to
the media. After 2 days, samples were fixed, stained, and
imaged as described above. The amount of fibronectin on the
surface was quantified by measuring the fluorescence intensity
in an area where the fibronectin layer looked uniform and
there were no cells or matrix fibers. The summed intensity was
divided by the area of the ROI and reported as fibronectin
density. One ROI per image was analyzed. Some images
showed abnormally high fluorescence intensity at the glass
surface. This could be due to autofluorescence from
HellmaneX solution that was not fully washed. These images
with abnormal coating were identified by viewing all images
simultaneously and they were excluded from the analysis.
Quantification of cell/nuclear markers and percentage of
coating harvested
Cell areas were estimated by manual tracing. Intensity of
F-actin, p-FAK, and p-MLC2 per cell were summed in the
manually traced cell outline after background subtraction.
Only spread cells with few cell–cell contacts were analyzed.
The percentage of the coating harvested per cell was measured
by setting a threshold to distinguish the intact coating and
fibronectin fibers from areas of the glass where the coating
had been removed (darker areas). The area below the threshold
was measured and divided by the total area to get the percen-
tage of the coating that was harvested. This value was then
divided by the number of cells identified by automatic seg-
mentation of the nuclei. YAP and MRTF-A nuclear-to-cyto-
plasmic ratios were measured manually in ImageJ software.
Lamin A, Lamin B, H3K9Ac, and H3K27me3 were quantified
by automatic nuclear segmentation in MATLAB.
Matrix assembly with FRET-labeled fibronectin
Fibroblasts were cultured in glass bottom Lab-tek chambers
(Thermo Fisher Scientific #155411) that had been previously
coated with unlabeled fibronectin (as described above). Cells
were plated at 10 000 cells per cm2 to achieve greater matrix
assembly and ensure that there was enough signal to analyze
FRET. After 1 hour cell adhesion, media were changed to
±Ficoll and supplemented with 100 μM L-ascorbic acid 2-phos-
phate, 45 μg mL−1 unlabeled fibronectin, and 5 μg mL−1 FRET-
labeled fibronectin. Cells were cultured for 2 days, then
washed with PBS and fixed with 4% PFA for 20 minutes.
Imaging of FRET in cell-assembled matrices
Samples were imaged in PBS immediately after fixation with
an Olympus FV1000 confocal microscope with a 40× water
immersion objective. Samples were excited with a 488 nm
laser and both the donor and acceptor emission were collected
simultaneously. Two day old matrices were imaged in one
focal plane where a majority of the matrix, particularly the
smallest fibers, were in focus. A Kalman line filter was applied
as a software setting at the time of image acquisition.
Analysis of FRET in cell-assembled matrices
Images of FRET labeled fibronectin were analyzed with
custom MATLAB code as described previously.54 Briefly, dark
current background from the detector was subtracted from
both the donor and acceptor images. Next, images were
smoothed with a 2 × 2 pixel averaging filter. A threshold was
applied to exclude low intensity signal from the fibronectin
coating and background (selecting only for fibronectin
fibers), as well as any saturated pixels. Then bleedthrough
from the donor channel into the acceptor channel was cor-
rected for by subtracting 20% of the donor image from the
acceptor image, pixel-by-pixel. Finally, FRET ratios were calcu-
lated by dividing the pixel intensities of the acceptor image
by the donor image.
Cross-linking fibronectin to the coverslip
For cross-linked fibronectin coating, coverslips were first
plasma treated (Harrick Plasma PDC-32G) for 30 seconds at
maximum power. Coverslips were then incubated for
15 minutes with 2% (3-aminopropyl)triethoxysilane (Sigma-
Aldrich #A3648) solution in DI water (made fresh). After
rinsing with DI water, coverslips were treated with 0.125% glu-
taraldehyde (Sigma-Aldrich #G4004) in water for 30 minutes.
Coverslips were washed again and coated with 50 μg mL−1
fibronectin in PBS for 1 hour. After washing with PBS, cover-
slips were sterilized with UV for 15 minutes before cell plating.
Cell culture proceeded as described above. Ascorbic acid was
supplemented to the media, but not plasma fibronectin.
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Unpaired, parametric t-tests were performed with GraphPad
Prism software to test for statistical significance. P-Values rela-
tive to control are indicated by stars in figures and defined in
figure captions.
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